UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Volltextzugriff (PDF)

Persistent complement activation on tumor cells in breast cancer

The American journal of pathology, 1992-05, Vol.140 (5), p.1039-1043

1992

Volltextzugriff (PDF)

TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects

Clinical immunology (Orlando, Fla.), 2009-07, Vol.132 (1), p.32-42

2009

Volltextzugriff (PDF)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Journal of neurology, neurosurgery and psychiatry, 2010-08, Vol.81 (8), p.907-912

2010

Volltextzugriff (PDF)

The Voltage-Gated Potassium Channel Kv1.3 Is Highly Expressed on Inflammatory Infiltrates in Multiple Sclerosis Brain

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (31), p.11094-11099

2005

Volltextzugriff (PDF)

Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis

Atherosclerosis, 1987-05, Vol.65 (1), p.1-11

1987

Volltextzugriff (PDF)

Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis

Journal of neuroimmunology, 2008-10, Vol.203 (1), p.94-103

2008

Volltextzugriff (PDF)

Immunoglobulins and complement components in human aortic atherosclerotic intima

Atherosclerosis, 1985-01, Vol.55 (1), p.35-50

1985

Volltextzugriff (PDF)

Complement C5 in Experimental Autoimmune Encephalomyelitis (EAE) Facilitates Remyelination and Prevents Gliosis

The American journal of pathology, 2003-09, Vol.163 (3), p.1069-1080

2003

Volltextzugriff (PDF)

Effects of Complement C5 on Apoptosis in Experimental Autoimmune Encephalomyelitis

The Journal of immunology (1950), 2004-05, Vol.172 (9), p.5702-5706

2004

Volltextzugriff (PDF)

Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries

Clinical and experimental immunology, 1987-08, Vol.69 (2), p.477-483

1987

Volltextzugriff (PDF)

Effects of Membrane Attack Complex of Complement on Apoptosis in Experimental Autoimmune Encephalomyelitis

Annals of the New York Academy of Sciences, 2003-12, Vol.1010 (1), p.530-533

2003

Volltextzugriff (PDF)

Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patients

Thrombosis and haemostasis, 1989-04, Vol.61 (2), p.270-274

1989

Volltextzugriff (PDF)

Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases

Clinical and experimental immunology, 1986-07, Vol.65 (1), p.66-72

1986

Volltextzugriff (PDF)

Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis

Immunology letters, 1987-10, Vol.16 (1), p.15-20

1987

Volltextzugriff (PDF)

Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia

Clinica chimica acta, 1985-04, Vol.147 (3), p.273-281

1985

Volltextzugriff (PDF)

Activation of the human terminal complement pathway in atherosclerosis

Clinical immunology and immunopathology, 1987-11, Vol.45 (2), p.147-155

1987

Volltextzugriff (PDF)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study

Clinical therapeutics, 2009-08, Vol.31 (8), p.1724-1736

2009

Volltextzugriff (PDF)

Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas

Medecine interne, 1988-01, Vol.26 (1), p.21

1988

Volltextzugriff (PDF)

Increased level of plasma factor VIII-related antigen in peripheral arterial disease

Medecine interne, 1985-07, Vol.23 (3), p.171

1985

Volltextzugriff (PDF)

Plasma fibronectin in peripheral arterial disease

Medecine interne, 1985-10, Vol.23 (4), p.271

1985

Volltextzugriff (PDF)

C5b-9 deposition in children with glomerular diseases

Medecine interne, 1987-04, Vol.25 (2), p.99

1987

Volltextzugriff (PDF)

Plasma fibronectin and factor XIII in nephrotic syndrome

Medecine interne, 1987-04, Vol.25 (2), p.105

1987

Volltextzugriff (PDF)

Immunologic alterations associated with chronic hemodialysis

Medecine interne, 1983-10, Vol.21 (4), p.289

1983

Volltextzugriff (PDF)

Quantitative determinations of immunoglobulins and complement components in human aortic atherosclerotic wall

Medecine interne, 1985-01, Vol.23 (1), p.29

1985

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(81)
Science & Technology
(70)
Male
(66)
Life Sciences & Biomedicine
(61)
Adult
(47)
Middle Aged
(41)
Biological And Medical Sciences
(24)
Aged
(22)
Adolescent
(17)
Animals
(17)
Medical Sciences
(17)
Child
(13)
Fundamental And Applied Biological Sciences. Psychology
(11)
Complement System Proteins - Analysis
(10)
General & Internal Medicine
(10)
Immunology
(10)
Medicine, General & Internal
(10)
Immunohistochemistry
(9)
Biomarkers
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Persistent complement activation on tumor cells in breast cancer

TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

The Voltage-Gated Potassium Channel Kv1.3 Is Highly Expressed on Inflammatory Infiltrates in Multiple Sclerosis Brain

Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis

Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis

Immunoglobulins and complement components in human aortic atherosclerotic intima

Complement C5 in Experimental Autoimmune Encephalomyelitis (EAE) Facilitates Remyelination and Prevents Gliosis

Effects of Complement C5 on Apoptosis in Experimental Autoimmune Encephalomyelitis

Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries

Effects of Membrane Attack Complex of Complement on Apoptosis in Experimental Autoimmune Encephalomyelitis

Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patients

Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases

Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis

Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia

Activation of the human terminal complement pathway in atherosclerosis

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study

Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas

Increased level of plasma factor VIII-related antigen in peripheral arterial disease

Plasma fibronectin in peripheral arterial disease

C5b-9 deposition in children with glomerular diseases

Plasma fibronectin and factor XIII in nephrotic syndrome

Immunologic alterations associated with chronic hemodialysis

Quantitative determinations of immunoglobulins and complement components in human aortic atherosclerotic wall

Aktive Filter

Suchergebnisse filtern